About Entogenex

Established in 2008, EntoGenex Industries Sdn Bhd (EntoGenex) is a Malaysia-based biotechnology company focused on vector control.

EntoGenex has pioneered green and sustainable solutions aimed at combating mosquito-transmitted diseases in Malaysia and worldwide. Towards this goal, EntoGenex has successfully incubated, developed and commercialised a range of mosquito control products utilising the Trypsin Modulating Oostatic Factor (TMOF) and EGX-101 technologies.

Our products utilising the TMOF and EGX-101 technologies have been successfully tested and their efficacy proven in field applications.

EntoGenex biolarvicide products using TMOF have been used in conjunction with the Komuniti Bebas Denggi government programme, as well as clients around the region including Singapore, while insect repellent products using EGX-101 are used by the Malaysia’s Ministry of Defence, Malaysian Olympic Athlete Delegation and sold at major retail outlets.

In 2009, EntoGenex was awarded the BioNexus status, an incentivised status given to accomplished biotechnology companies, from the Malaysian Biotechnology Corporation. The company is also a proud recipient of a RM 3.365 million TechnoFund Grant from the Ministry of Science, Technology and Innovation for the commercial development of its biopesticide products.

With its recent successes, EntoGenex is moving towards international expansion, promoting unique solutions in combating mosquito transmitted diseases on a global platform.

EntoGenex Industries Sdn Bhd(EntoGenex)成立于2008年,是一家专注于防治虫害传播疾病的马来西亚生物科技公司。



EntoGenex生物杀幼虫剂产品使用TMOF技术,不但使用于Komuniti Bebas Denggi(KBD- 社区摆脱登革热)政府计划,还有包括新加坡在内的本区域的客户一起使用。含有EGX-101的驱虫产品,则被马来西亚国防部、马来西亚奥运会运动员代表团所采纳使用,并在主要零售店铺出售。




Show Buttons
Hide Buttons